In patients who have experienced myocardial infarction (MI), a moderately reduced level (≤ 35%) of left-ventricular ejection fraction (LVEF) is indicated as the threshold at which cardiologists should consider an implantable cardioverter-defibrillator (ICD), to reduce the likelihood of sudden cardiac death (SCD). Nonetheless, recent studies have indicated that patients with … [Read more...] about Arrhythmic risk stratification of post-MI patients with preserved ejection fraction identifies high risk subgroup
Electrophysiology
ACC 2019 – What you need to know
American College of Cardiology Meeting March 16 – 18 , 2019 (New Orleans, LA) HEART FAILURE CardioMEMS PAS trial1: The use of a CardioMEMS sensor (monitoring pulmonary artery pressure) in 1200 heart failure (HF) patients resulted in a 58% reduction in HF-related hospitalization rate in the year following the sensor placement as compared to the previous year. IMAGING … [Read more...] about ACC 2019 – What you need to know
Wearable Cardioverter-Defibrillator could not reduce arrhythmic death after Myocardial Infarction
Patients with myocardial infarction, particularly with a low left ventricular ejection fraction, have a high incidence of sudden cardiac death during the early months after the event. Implantable cardioverter-defibrillators are contraindicated until 40-90 days after myocardial infarction (MI). A wearable device could potentially protect against sudden death during this … [Read more...] about Wearable Cardioverter-Defibrillator could not reduce arrhythmic death after Myocardial Infarction